Sangamo Therapeutics
SGMO
#8849
Rank
A$0.22 B
Marketcap
A$0.68
Share price
-1.98%
Change (1 day)
-77.46%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$32.87 Million. In 2024 the company made an earning of -A$0.15 Billion, an increase over its 2023 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion15.21%
2024 -A$0.15 Billion-17.27%
2023 -A$0.18 Billion-40.88%
2022 -A$0.31 Billion9.79%
2021 -A$0.28 Billion41.52%
2020 -A$0.2 Billion23.17%
2019 -A$0.16 Billion36.33%
2018 -A$0.12 Billion36.89%
2017 -A$84.57 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$70.31 Million75.62%
2014 -A$40.04 Million0.13%
2013 -A$39.98 Million
2011 -A$53.75 Million43.66%
2010 -A$37.42 Million28.52%
2009 -A$29.12 Million-23.55%
2008 -A$38.08 Million2.45%
2007 -A$37.17 Million19.5%
2006 -A$31.11 Million50.78%
2005 -A$20.63 Million75%
2004 -A$11.79 Million-33.25%
2003 -A$17.66 Million-62.27%
2002 -A$46.81 Million102.82%
2001 -A$23.08 Million23.21%
2000 -A$18.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$14.83 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.19 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.36 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.85 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$1.12 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.60 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.01 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.64 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA